317
Participants
Start Date
May 17, 2020
Primary Completion Date
July 23, 2021
Study Completion Date
August 30, 2021
Zinforo (ceftaroline fosamil)
IV Solution
Hospital Universitario Valle de Hebrón, Barcelona
Aou Citta Della Salute E Della Scienza Scdu Malattie Infettive 2, Turin
Attikon University General Hospital, Athens
CHU Francois Mitterrand, Dijon
Asst Spedali Civili Brescia and Universita Degli Studi di Brescia, Brescia
Patras University Medical School, Pátrai
Hospital Ramon y Cajal, Madrid
Hospital Universitario 12 de Octubre, Madrid
Azienda Sanitaria Universitaria Friuli Centrale (ASU FC), Presidio Ospedaliero Universitario Santa, Udine
CHU de Grenoble Alpes, Grenoble
General University Hospital of Larissa, Larissa
CHU Nantes, Nantes
Clínica Las Américas, Medellín
AHEPA General University Hospital of Thessaloniki, Thessaloniki
Croix-Rousse hospital, Hospices Civils de Lyon, Lyon
University Hospital of Heraklion, Heraklion
AORN Ospedali dei Colli - Ospedale Monaldi, Napoli
Azienda Ospedaliera Dei Colli, Napoli
BUZ UR First Republican Clinical Hospital under the Ministry of Healthcare of Udmurt Republic UR, Izhevsk
Republican Clinical Hospital named after G.G. Kuvatova, Ufa
E.S.E. Hospital Universitario San Jorge de Pereira, Pereira
Fundación Valle del Lili, Santiago de Cali
Real Hospital Português de Beneficência, Recife
Hospital Esperança, Recife
Centro médico Imbanaco, Santiago de Cali
Hospital Clínic, Barcelona
Lead Sponsor
Pfizer
INDUSTRY